Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor imaging in nuclear medicine]

K Uno1, J Kuyama, Y Uchida

  • 1Department of Radiology, Chiba University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 1, 1996
PubMed
Summary

Advancements in nuclear medicine tumor imaging include a novel three-detector SPECT system and new radiopharmaceuticals. These innovations enhance scanning speed, image resolution, and detection of various cancers, including metastatic lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of the Radiative Decay D_{s0}^{*}(2317)^{+}→D_{s}^{*+}γ.

Physical review letters·2026
Same author

First Search for B→X_{s}νν[over ¯] Decays.

Physical review letters·2026
Same author

Search for Feebly Interacting Particles in B Decays with Missing Energy at Belle.

Physical review letters·2026
Same author

Recommendations for effective dissemination of scientific information, based on the analyses of Twitter data concerning radiation after the Fukushima nuclear accident.

Annals of the ICRP·2026
Same author

Search for B^{0}→K^{*0}τ^{+}τ^{-} Decays at the Belle II Experiment.

Physical review letters·2025
Same author

Search for a Dark Higgs Boson Produced in Association with Inelastic Dark Matter at the Belle II Experiment.

Physical review letters·2025

Area of Science:

  • Nuclear Medicine
  • Medical Imaging
  • Oncology

Background:

  • Nuclear medicine tumor imaging relies on advanced instrumentation and radiopharmaceuticals.
  • Early detection of metastatic lesions and various tumor types is crucial for effective treatment.

Purpose of the Study:

  • To highlight recent improvements in tumor imaging within nuclear medicine.
  • To discuss the benefits of a three-detector SPECT system and novel radiopharmaceuticals.

Main Methods:

  • Utilized a three-detector SPECT system with 120-degree detector rotation for data acquisition.
  • Reviewed common radiopharmaceuticals like 99mTc MDP, 57Ga-citrate, 201Tl chloride, and 99mTc MIBI.
  • Introduced 111In-DTPA-D-Phe-octreotide for somatostatin receptor detection.

Related Experiment Videos

Main Results:

  • The three-detector SPECT system offers reduced scanning time and high-resolution images (<10 mm FWHM).
  • Established radiopharmaceuticals are effective for early metastatic lesion detection.
  • New agents like 111In-DTPA-D-Phe-octreotide show promise for specific tumor types.

Conclusions:

  • Technological and pharmaceutical advancements are significantly improving nuclear medicine tumor imaging.
  • The new SPECT system and radiopharmaceuticals enhance diagnostic capabilities for a range of cancers.